Newly installed Ombudsman Jesus Crispin Remulla on Thursday said he intends to review the corruption scandal involving Pharmally Pharmaceutical Corporation.
Remulla made this statement amid calls to revisit the 2021 Pharmally scandal. ‘We’ll take a look at that because it seems like it’s been forgotten, buried in oblivion,’ Remulla said in an interview.
‘But these kinds of cases shouldn’t really be forgotten because we know the allegations have weight, and many are saying that something bad happened there,’ the ombudsman stressed.
‘The Senate had a hearing but did not move forward from there,’ he recalled. ‘So we need to revisit it.’
Article continues after this advertisement
When asked if the reopening of the investigation might involve former President Rodrigo Duterte, Remulla said he was unsure.
‘The responsibility will always depend on the evidence,’ Remulla said.
‘We will go as far as the evidence takes us,’ he told reporters. Pharmally is the pharmaceutical corporation that was investigated by the Senate over alleged irregularities in government deals worth billions of pesos for COVID-19 response supplies despite having a paid-up capital of only P625,000. /apl